78 LiQ.LiangJ.FuN.HanY.QinJ
One of the most consequential changes in 2026 is the loss of exclusivity for semaglutide, beginning in early 2026 across major markets including India, China, Brazil, Turkey and Canada, with semaglutide having lost exclusivity in India on 20th March 2026
New research from Blue Cross Blue Shield reveals that, among 170,000 patients using a GLP-1 for weight management, 58% discontinued use before reaching a clinically meaningful health benefit
This blend helps your body break down fats more effectively, promoting weight management and boosting overall vitality
Bullying a Dragon: SpongeBob, Patrick, and other "jellyfishers" do this as an everyday hobby, walking straight up to deadly, weaponized animals and catching them in nets
American Diabetes Association Professional Practice Committee